94.06
price up icon3.82%   3.46
after-market Handel nachbörslich: 94.06
loading
Schlusskurs vom Vortag:
$90.60
Offen:
$90.52
24-Stunden-Volumen:
344.88K
Relative Volume:
0.73
Marktkapitalisierung:
$2.04B
Einnahmen:
$747.40M
Nettoeinkommen (Verlust:
$-12.60M
KGV:
-122.36
EPS:
-0.7687
Netto-Cashflow:
$105.18M
1W Leistung:
+1.29%
1M Leistung:
+4.93%
6M Leistung:
+28.94%
1J Leistung:
+61.64%
1-Tages-Spanne:
Value
$88.96
$94.25
1-Wochen-Bereich:
Value
$88.96
$94.25
52-Wochen-Spanne:
Value
$52.50
$99.50

Ani Pharmaceuticals Inc Stock (ANIP) Company Profile

Name
Firmenname
Ani Pharmaceuticals Inc
Name
Telefon
(218) 634-3500
Name
Adresse
210 MAIN STREET WEST, BAUDETTE, MN
Name
Mitarbeiter
897
Name
Twitter
Name
Nächster Verdiensttermin
2025-08-08
Name
Neueste SEC-Einreichungen
Name
ANIP's Discussions on Twitter

Vergleichen Sie ANIP mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
ANIP
Ani Pharmaceuticals Inc
94.06 2.02B 747.40M -12.60M 105.18M -0.7687
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
144.35 63.86B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.42 42.46B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.38 41.28B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.52 23.49B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
438.66 19.18B 3.08B 1.24B 1.07B 25.61

Ani Pharmaceuticals Inc Stock (ANIP) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-10 Eingeleitet H.C. Wainwright Buy
2025-03-14 Eingeleitet Jefferies Buy
2025-03-12 Eingeleitet JP Morgan Overweight
2024-12-11 Eingeleitet Leerink Partners Outperform
2024-10-11 Eingeleitet Piper Sandler Overweight
2024-03-15 Eingeleitet CapitalOne Overweight
2023-08-22 Bestätigt H.C. Wainwright Buy
2023-03-01 Eingeleitet Guggenheim Buy
2022-09-07 Eingeleitet H.C. Wainwright Buy
2021-11-02 Eingeleitet Truist Buy
2020-05-07 Herabstufung Cantor Fitzgerald Overweight → Neutral
2019-09-12 Eingeleitet Guggenheim Buy
2019-05-10 Herabstufung Raymond James Strong Buy → Outperform
2017-10-16 Bestätigt Canaccord Genuity Buy
2017-07-31 Eingeleitet Canaccord Genuity Buy
2017-02-22 Herabstufung ROTH Capital Buy → Neutral
2016-06-23 Eingeleitet Raymond James Strong Buy
2016-05-24 Herabstufung Standpoint Research Buy → Hold
2015-11-13 Eingeleitet Standpoint Research Buy
2015-09-28 Hochstufung ROTH Capital Neutral → Buy
2015-08-05 Bestätigt Oppenheimer Outperform
2015-08-04 Bestätigt ROTH Capital Neutral
2015-07-31 Bestätigt Oppenheimer Outperform
2015-07-15 Bestätigt ROTH Capital Neutral
2015-06-23 Bestätigt Oppenheimer Outperform
2015-05-18 Bestätigt ROTH Capital Neutral
2015-05-06 Bestätigt Oppenheimer Outperform
2015-04-10 Herabstufung ROTH Capital Buy → Neutral
2015-02-26 Bestätigt ROTH Capital Buy
2015-02-18 Bestätigt Oppenheimer Outperform
Alle ansehen

Ani Pharmaceuticals Inc Aktie (ANIP) Neueste Nachrichten

pulisher
09:36 AM

Smart tools for monitoring ANI Pharmaceuticals Inc.’s price actionWeekly Trend Summary & Fast Entry High Yield Stock Tips - newser.com

09:36 AM
pulisher
08:10 AM

Why ANI Pharmaceuticals Inc. (BSFA) stock is a strong buy callGlobal Markets & Detailed Earnings Play Alerts - newser.com

08:10 AM
pulisher
05:33 AM

What insider trading reveals about ANI Pharmaceuticals Inc. stockQuarterly Trade Review & High Conviction Buy Zone Alerts - newser.com

05:33 AM
pulisher
05:14 AM

Will ANI Pharmaceuticals Inc. (BSFA) stock boost dividends further2025 Pullback Review & Long Hold Capital Preservation Tips - newser.com

05:14 AM
pulisher
04:17 AM

Can ANI Pharmaceuticals Inc. stock continue upward trendWeekly Risk Summary & Smart Allocation Stock Reports - newser.com

04:17 AM
pulisher
02:53 AM

Using flow based indicators on ANI Pharmaceuticals Inc.2025 Technical Patterns & Long-Term Growth Portfolio Plans - newser.com

02:53 AM
pulisher
12:11 PM

ANI Pharmaceuticals (ANIP): Evaluating Valuation After Strong 2024 Share Price Gains - Yahoo Finance

12:11 PM
pulisher
Nov 02, 2025

Applying Elliott Wave Theory to ANI Pharmaceuticals Inc.Market Risk Report & Real-Time Volume Trigger Notifications - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is ANI Pharmaceuticals Inc. stock attractive for growth ETFsJuly 2025 Summary & Weekly Stock Performance Updates - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is ANI Pharmaceuticals Inc. stock cheap at current valuation2025 Risk Factors & Daily Stock Trend Watchlist - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Predicting ANI Pharmaceuticals Inc. trend using moving averagesQuarterly Risk Review & Technical Entry and Exit Tips - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

What indicators show strength in ANI Pharmaceuticals Inc.Weekly Investment Report & Long-Term Safe Return Strategies - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

ANI Pharmaceuticals (NASDAQ:ANIP) Has A Somewhat Strained Balance Sheet - 富途牛牛

Nov 01, 2025
pulisher
Nov 01, 2025

Why ANI Pharmaceuticals Inc. stock could rally in 2025Weekly Stock Summary & Safe Entry Zone Identification - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Published on: 2025-11-01 04:07:10 - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance

Oct 31, 2025
pulisher
Oct 31, 2025

Published on: 2025-10-31 04:42:45 - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Published on: 2025-10-31 04:40:15 - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

How ANI Pharmaceuticals Inc. stock trades during market volatility2025 Investor Takeaways & Risk Controlled Stock Pick Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Regression analysis insights on ANI Pharmaceuticals Inc. performanceWeekly Market Report & Safe Entry Point Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

ANI Pharmaceuticals (ANIP) to Release Earnings on Friday - MarketBeat

Oct 31, 2025
pulisher
Oct 30, 2025

ANI Pharmaceuticals, Inc. (ANIP) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK

Oct 30, 2025
pulisher
Oct 30, 2025

Reversal indicators forming on ANI Pharmaceuticals Inc. stockExit Point & Intraday High Probability Setup Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

ANI Pharmaceuticals, Inc. $ANIP Shares Purchased by Teacher Retirement System of Texas - MarketBeat

Oct 30, 2025
pulisher
Oct 29, 2025

ANI Pharmaceuticals, Inc. (ANIP) Stock Forecasts - Yahoo! Finance Canada

Oct 29, 2025
pulisher
Oct 29, 2025

ANI Pharma wins Overweight rating at J.P. Morgan on growth prospects - MSN

Oct 29, 2025
pulisher
Oct 29, 2025

Mizuho Markets Americas LLC Buys 15,357 Shares of ANI Pharmaceuticals, Inc. $ANIP - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

What high frequency data says about ANI Pharmaceuticals Inc.Weekly Investment Report & Fast Moving Trade Plans - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

ANI Pharmaceuticals Inc Stock Analysis and ForecastMarket Rumors and News & Trade Like a Pro Using AI Edge - earlytimes.in

Oct 28, 2025
pulisher
Oct 28, 2025

ANI Pharmaceuticals: Strong Buy On Rare Disease Growth, Record Of Beating Estimates - Seeking Alpha

Oct 28, 2025
pulisher
Oct 28, 2025

What dividend safety score for ANI Pharmaceuticals Inc. stockTrade Performance Summary & Low Risk High Win Rate Picks - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

Will ANI Pharmaceuticals Inc. stock benefit from automationEarnings Growth Report & Weekly High Potential Stock Alerts - fcp.pa.gov.br

Oct 28, 2025
pulisher
Oct 28, 2025

Will ANI Pharmaceuticals Inc. stock maintain growth storyJuly 2025 PostEarnings & High Win Rate Trade Tips - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 27, 2025

Has ANI Pharmaceuticals (ANIP) Outpaced Other Medical Stocks This Year? - sharewise.com

Oct 27, 2025

Finanzdaten der Ani Pharmaceuticals Inc-Aktie (ANIP)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$44.39
price down icon 2.35%
drug_manufacturers_specialty_generic RDY
$13.41
price up icon 0.90%
$22.85
price up icon 3.16%
$10.53
price up icon 1.64%
$141.96
price down icon 0.87%
$438.66
price down icon 1.52%
Kapitalisierung:     |  Volumen (24h):